2-47373967-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002354.3(EPCAM):​c.344T>C​(p.Met115Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.478 in 1,613,628 control chromosomes in the GnomAD database, including 193,996 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M115I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.58 ( 27738 hom., cov: 31)
Exomes 𝑓: 0.47 ( 166258 hom. )

Consequence

EPCAM
NM_002354.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.0500

Publications

77 publications found
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
EPCAM Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Lynch syndrome 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital diarrhea 5 with tufting enteropathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.3098158E-6).
BP6
Variant 2-47373967-T-C is Benign according to our data. Variant chr2-47373967-T-C is described in ClinVar as Benign. ClinVar VariationId is 183700.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.824 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPCAMNM_002354.3 linkc.344T>C p.Met115Thr missense_variant Exon 3 of 9 ENST00000263735.9 NP_002345.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPCAMENST00000263735.9 linkc.344T>C p.Met115Thr missense_variant Exon 3 of 9 1 NM_002354.3 ENSP00000263735.4

Frequencies

GnomAD3 genomes
AF:
0.577
AC:
87547
AN:
151766
Hom.:
27689
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.831
Gnomad AMI
AF:
0.354
Gnomad AMR
AF:
0.494
Gnomad ASJ
AF:
0.363
Gnomad EAS
AF:
0.817
Gnomad SAS
AF:
0.498
Gnomad FIN
AF:
0.591
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.443
Gnomad OTH
AF:
0.526
GnomAD2 exomes
AF:
0.513
AC:
129014
AN:
251424
AF XY:
0.501
show subpopulations
Gnomad AFR exome
AF:
0.842
Gnomad AMR exome
AF:
0.472
Gnomad ASJ exome
AF:
0.363
Gnomad EAS exome
AF:
0.832
Gnomad FIN exome
AF:
0.596
Gnomad NFE exome
AF:
0.436
Gnomad OTH exome
AF:
0.464
GnomAD4 exome
AF:
0.467
AC:
683281
AN:
1461744
Hom.:
166258
Cov.:
45
AF XY:
0.466
AC XY:
338676
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.849
AC:
28436
AN:
33480
American (AMR)
AF:
0.474
AC:
21210
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.368
AC:
9609
AN:
26134
East Asian (EAS)
AF:
0.790
AC:
31354
AN:
39700
South Asian (SAS)
AF:
0.480
AC:
41378
AN:
86258
European-Finnish (FIN)
AF:
0.592
AC:
31632
AN:
53414
Middle Eastern (MID)
AF:
0.383
AC:
2208
AN:
5768
European-Non Finnish (NFE)
AF:
0.438
AC:
487525
AN:
1111880
Other (OTH)
AF:
0.496
AC:
29929
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
20970
41939
62909
83878
104848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14996
29992
44988
59984
74980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.577
AC:
87649
AN:
151884
Hom.:
27738
Cov.:
31
AF XY:
0.582
AC XY:
43171
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.831
AC:
34451
AN:
41454
American (AMR)
AF:
0.494
AC:
7513
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
1262
AN:
3472
East Asian (EAS)
AF:
0.816
AC:
4214
AN:
5164
South Asian (SAS)
AF:
0.498
AC:
2400
AN:
4820
European-Finnish (FIN)
AF:
0.591
AC:
6210
AN:
10504
Middle Eastern (MID)
AF:
0.361
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
0.442
AC:
30066
AN:
67946
Other (OTH)
AF:
0.525
AC:
1105
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1667
3334
5001
6668
8335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.480
Hom.:
63144
Bravo
AF:
0.580
TwinsUK
AF:
0.446
AC:
1654
ALSPAC
AF:
0.435
AC:
1676
ESP6500AA
AF:
0.828
AC:
3649
ESP6500EA
AF:
0.433
AC:
3722
ExAC
AF:
0.520
AC:
63080
Asia WGS
AF:
0.658
AC:
2287
AN:
3478
EpiCase
AF:
0.422
EpiControl
AF:
0.412

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27153395, 20683652, 22322561) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital diarrhea 5 with tufting enteropathy Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lynch syndrome 1 Benign:1
Aug 18, 2017
IntelligeneCG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lynch syndrome 8 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jan 16, 2013
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.040
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Benign
0.74
DEOGEN2
Benign
0.0039
T;T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.018
.;T;T
MetaRNN
Benign
0.0000033
T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-1.4
.;N;.
PhyloP100
0.050
PrimateAI
Benign
0.31
T
PROVEAN
Benign
2.2
N;N;N
REVEL
Benign
0.18
Sift
Benign
1.0
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.020
MPC
0.013
ClinPred
0.0024
T
GERP RS
1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.36
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126497; hg19: chr2-47601106; COSMIC: COSV55392922; COSMIC: COSV55392922; API